GLP-1 Mounjaro Crosses a New Threshold
Mounjaro just crossed a threshold no other GIP/GLP-1 medication has crossed before. The FDA has approved it specifically to reduce the risk of major cardiovascular events, heart attack, stroke, and … Continue readingGLP-1 Mounjaro Crosses a New Threshold
